Results 101 to 110 of about 595 (117)

Antimalarial drug resistance and drug discovery: learning from the past to innovate the future. [PDF]

Int J Parasitol Drugs Drug Resist
Theodoridis L, Carvalho TG.
europepmc   +1 more source

PNGaseL from Flavobacterium akiainvivens targets a diverse range of N-glycan structures

Bakshani CR, Urbanowicz PA, Tortosa CB, Diaz JMM, Kujawska M, Ojuri TO, Hall LJ, Spencer DI, Bolam DN, Crouch LI.   +9 more
europepmc   +1 more source

Sweet Bee Venom Triggers Multiple Cell Death Pathways or Spurs Acute Cell Rupture According to Its Concentration in THP-1 Monocytic Leukemia Cells [PDF]

Genes, 2022
Jae-Min Ryu, Han-Heom Na, Yoon-Jong Park   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Bee Venom: From Venom to Drug

Molecules, 2021
Abdelwahab Khalil, Basem H Elesawy, Tarek M Ali   +2 more
exaly  

Pharmacokinetic improvement provided by microneedle patch in delivering bee venom, a case study in combating scopolamine-induced neurodegeneration in mouse model

Drug Delivery, 2022
Cong Duc Nguyen, Do Hyeon Jeong, Soo-Yeon Park   +2 more
exaly  

Effects of Sweet Bee Venom Pharmacopuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy

Integrative Cancer Therapies, 2012
Jae-Woo Park, Ju-Hyun Jeon, Tae-Young Jung   +2 more
exaly  

봉약침(Bee Venom)과 Sweet Bee Venom의 Allergy 반응에 대한 비교연구

Journal of Korean Pharmacopuncture Institute, 2006
openaire   +1 more source

Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy

Cancer Letters, 2017
Islam Rady, Imtiaz A Siddiqui, Hasan Mukhtar   +2 more
exaly  

Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests

Molecules, 2019
Rim Wehbe, Jacinthe Frangieh, Mohamad Rima   +2 more
exaly  

Clinical Effectiveness and Adverse Events of Bee Venom Therapy: A Systematic Review of Randomized Controlled Trials

Toxins, 2020
Soobin Jang, Kyeong Han Kim
exaly